“The move comes after Shkreli, its former CEO, was charged on December 17 in federal court with securities fraud related to a hedge fund and another company. Shkreli pleaded not guilty to the charges. Shkreli initially gained notoriety in September when, as the chief executive of Turing Pharmaceuticals, he raised the price of Daraprim— a drug used to treat a dangerous parasitic infection— from $13.50 to $750 per pill. The move generated harsh criticism from prominent politicians, including Hillary Clinton, and spurred a senate investigation into drug pricing.”
http://www.nydailynews.com/news/national/martin-shkreli-company-files-bankruptcy-article-1.2481147
Did you like this?
Tip Freedomwat.ch Staff with Bitcoin
Tip Freedomwat.ch Staff with Bitcoin
Related posts:
Egypt closes Gaza border crossing indefinitely
Netanyahu lost his Iran bet, but his next gamble may be disastrous
Cyber security battle looms after Obama issues executive order
President Obama and his secret executive friends
In trial over OKC bombing evidence, FBI accused of threatening witness
China's state newspaper praises Edward Snowden for 'tearing off Washington's sanctimonious mask'
White House to Give Detroit $300 Million in Federal Aid
Every cloud has a gold lining
US aiding Saudi 'war crimes' in Yemen: Congressman
Am Law Lawyers Help Bring Bitcoin to the Masses
Corporate bond rates go negative
Gold Fix Study Shows Signs of Decade of Bank Manipulation
China lifts curtain on landmark reform agenda
Tunisian women ‘waging sex jihad in Syria’
Businesses in Berlin open arms to digital currency Bitcoin